
IPA Market Capitalization Overview
Market Cap: $32.11M as of Jun 13, 2025
$32.11M
Past Month+$20.02M (165.52%)
As of Jun 13, 2025, IPA has a market capitalization of $32.11M. Over the past 30 days, its market cap has increased by 23.57%, while in the last 12 months, it has increased by 212.73%.
Market capitalization represents the total value of Immunoprecise Antibodies Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
IPA Market Cap Formula = Stock Price * Shares Outstanding
The market cap of IPA helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Immunoprecise Antibodies Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
IPA Market Cap Formula = Stock Price * Shares Outstanding
The market cap of IPA helps investors assess the company's size and compare it with competitors for better investment decisions.
IPA Market Cap & Key Trends
See Immunoprecise Antibodies Ltd’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in IPA
Order type
Buy in
Order amount
Est. shares
0 shares
IPA Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $14.25M | +23.57% |
May 1, 2025 | $11.54M | +28.27% |
Apr 1, 2025 | $8.99M | +9.51% |
Mar 3, 2025 | $8.21M | -25.35% |
Feb 3, 2025 | $10.99M | -2.00% |
Jan 2, 2025 | $11.23M | +19.68% |
IPA End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $32.11M | +212.73% |
2024 | $10.27M | -75.92% |
2023 | $42.64M | -67.18% |
2022 | $129.92M | +24.74% |
2021 | $104.15M | -58.56% |
2020 | $251.29M | — |
FAQs About Immunoprecise Antibodies Ltd (IPA) Market Cap
As of Jun 13, 2025, the market capitalization of IPA is $32.11M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Immunoprecise Antibodies Ltd’s market capitalization has increased by 165.52%, changing from $12.10M to $32.11M as of Jun 13, 2025.
In the last 3 months, Immunoprecise Antibodies Ltd’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, Immunoprecise Antibodies Ltd’s market capitalization decreased from $42.64M in January to $10.27M in December, reflecting a -75.92% change.
In the past five years, IPA has had a compound annual growth rate (CAGR) of -47.25% in market capitalization. This means its market cap has shrunk at an average rate of -47.25% per year.